CHARACTERISTICS OF INFILTRATIVE PULMONARY TUBERCULOSIS IN PATIENTS WITH CONCOMITANT PEPTIC ULCER DISEASE AND HIV INFECTION
Article Sidebar
Main Article Content
Abstract
Infiltrative pulmonary tuberculosis (IPTB) is one of the most common clinical forms of tuberculosis and is most frequently observed among individuals of working age. Over recent decades, a steady increase in comorbid and multimorbid conditions associated with tuberculosis has been noted, significantly affecting the clinical course, diagnostic features, and treatment effectiveness of the disease. The combination of infiltrative pulmonary tuberculosis with peptic ulcer disease and HIV infection is considered particularly unfavorable.
HIV infection leads to progressive immunosuppression, resulting in a paucisymptomatic, atypical, and indolent course of tuberculosis. Consequently, the disease is often diagnosed at advanced stages, treatment duration is prolonged, and the risk of complications increases. At the same time, gastrointestinal disorders, including gastric and duodenal ulcer disease, are highly prevalent among HIV-infected patients. One of the leading etiological factors of peptic ulcer disease is Helicobacter pylori infection, which is also detected with high frequency in patients with tuberculosis.
The most unfavorable clinical prognosis is observed in patients with infiltrative pulmonary tuberculosis combined with H. pylori-negative peptic ulcer disease.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1.Abdukarimov M. U., Kh U. I. The study of the prognostic value of procalcitonin and changes in the blood coagulation system in the course of pulmonary tuberculosis //Journal of Survey in Fisheries Sciences. – 2023. – Т. 10. – №. 1S. – С. 3217-3247.
2.Abdukarimov M. U., Usmonov I. K. Changes in the blood coagulation system in destructive tuberculosis //Central Asian Journal of Medicine. – 2024. – №. 3. – С. 111-117.
3.Abdukarimov M. U., Kh U. I. 67-7 (69) 2024-Abdukarimov MU, Usmonov I. Kh.-pathogenesis of the origin of destructive forms of pulmonary tuberculosis: review of scientific sources.
4.Usmonov I., Shukurov U. Features of the clinical course, the state of diagnosis and treatment of HIV-associated pulmonary tuberculosis in modern conditions literature review //Annals of the Romanian Society for Cell Biology. – 2021. – Т. 25. – №. 4. – С. 1809-1828.
5.Usmonov I. K., Muazzamov B. R., Jumaev M. F. Features of Diagnostics and Treatment of Drug-Resistant Forms of Pulmonary Tuberculosis //International Journal of Pharmaceutical Research (09752366). – 2020. – Т. 12. – №. 3.
6.Парпиева Н. Н. и др. Особенности диагностики и лечении при генерализированных формах туберкулёза //Новый день в медицине. Бухара,(2). – 2020. – С. 424-428.
7.Khaydarovich U. I., Khodgamovich N. P. Technique of use of titanium mesh cylinder of exemplary cage tubercular spondylitis //European science review. – 2018. – №. 9-10-2. – С. 178-184.
8.Назиров П. Х. и др. Преимущество и недостатки боковых хирургических доступов при радикально-восстановительных оперatsiях туберкулёзного спондилита поясничного и пояснично-крестцового отдела позвоночника //Новый день в медицине. – 2020. – №. 2. – С. 453-458.
9.Usmonov I. X., Iskandarova I. M. Xavfli o‘smalar va o‘pka tuberkulyozini davolashda klinik va diagnostik xususiyatlar hamda qiyinchiliklar //Журнал гуманитарных и естественных наук. – 2024. – №. 8. – С. 113-117.
10.Усмонов И. Х., Гобилов Н. Ю. Особенности лечения при генерализированных формах туберкулёза //Молодой ученый. – 2020. – №. 29. – С. 65-68.
11.Назиров П. Х., Усмонов И. Х., Зайиров М. Х. Состояние очагов туберкулезной инфекции в современных условиях //Вестник Ассоциatsiи Пульмонологов Центральной Азии. – 2025. – Т. 14. – №. 9. – С. 362-366.
12.Усмонов И. Х. и др. Особенности пост лечебных морфологических изменений мульти резистентных формах туберкулёза легких и оценка его прогностической значимости //Ta'limning zamonaviy transformatsiyasi. – 2025. – Т. 19. – №. 1. – С. 202-206.
13.Аслонов Ф. И., Усмонов И. Х. Влияние гендерных и клинических факторов на исходы лечения туберкулёза: сравнительный анализ первичных и вторичных пatsiентов //International Conference on Modern Science and Scientific Studies. – 2025. – С. 51-53.
14.Усмонов И. Х., Умурова Д. О. Особенности клинического течения туберкулезного спондилита у больных с сердечной потологией //Наука и инновatsiя. – 2024. – Т. 2. – №. 32. – С. 62-64.
15.Ливерко И. В., Абдуганиева Э. А. Связь патогенетических механизмов развития инфаркта миокарда с хронической обструктивной болезнью легких: причины и факторы риска (обзор) //Georgian medical. – 2019. – С. 66.
16.Абдуганиева Э. А., Халмухаммедова С. М., Дадабаева Р. К. Влияние изменения образа жизни и характера питания на качество жизни пatsiентов с ХОБЛ //В сборнике: Особенности формирования здорового образа жизни: факторы и условия. – 2015.
17.Fatullayevich J. M. Biological characteristics of the causative agent of tuberculosis in patients with pulmonary tuberculosis //World Bulletin of Public Health. – 2021. – Т. 5. – С. 27-32.
18.Jumayev M. F. Characteristics and shortcomings of clinical and medical diagnostics of pulmonary tuberculosis // Barqarorlik va Yetakchi Tadqiqotlar Online Scientific Journal. – 2022. – Vol. 2. – No. 10. – Pp. 367–372.